Targeting YB-1 via entinostat enhances cisplatin sensitivity of pleural mesothelioma in vitro and in vivo.
Schelch K, Emminger D, Zitta B, Johnson TG, Kopatz V, Eder S, Ries A, Stefanelli A, Heffeter P, Hoda MA, Hoetzenecker K, Dome B, Berger W, Reid G, Grusch M.
Schelch K, et al. Among authors: heffeter p.
Cancer Lett. 2023 Oct 10;574:216395. doi: 10.1016/j.canlet.2023.216395. Epub 2023 Sep 18.
Cancer Lett. 2023.
PMID: 37730104
Free article.